Effect of STING agonist on tumor immune microenvironment of non-inflamed lung cancer and efficacy of immune checkpoint blockade.

被引：3

作者：

Chon, Hongjae ^{[1
]}

机构：

[1] CHA Hosp, Seongnam, South Korea

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 05期

关键词：

D O I：

10.1200/JCO.2018.36.5_suppl.178

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

178

引用

页数：1

共 50 条

[31] A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment
Wei, Cheng-Hsin
Huang, Lu
Kreh, Blair
Liu, Xiuxia
Tyutyunyk-Massey, Liliya
Kawakami, Masanori
Chen, Zibo
Shi, Mi
Kozlov, Serguei
Chan, King C.
Andresson, Thorkell
Carrington, Mary
Vuligonda, Vidyasagar
Sanders, Martin E.
Horowitz, Amir
Hwu, Patrick
Peng, Weiyi
Dmitrovsky, Ethan
Liu, Xi
SCIENTIFIC REPORTS, 2023, 13 (01)
[32] A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment
Cheng-Hsin Wei
Lu Huang
Blair Kreh
Xiuxia Liu
Liliya Tyutyunyk-Massey
Masanori Kawakami
Zibo Chen
Mi Shi
Serguei Kozlov
King C. Chan
Thorkell Andresson
Mary Carrington
Vidyasagar Vuligonda
Martin E. Sanders
Amir Horowitz
Patrick Hwu
Weiyi Peng
Ethan Dmitrovsky
Xi Liu
Scientific Reports, 13
[33] Depletion of stromal cells remodels tumor microenvironment and potentiates immune checkpoint blockade in pancreatic cancer
Rupert, Joseph
Daquinag, Alexes
Cai, Lingyi
Dai, Yulin
Zhao, Zhongming
Anastassiou, Dimitris
Kolonin, Mikhail
CANCER RESEARCH, 2024, 84 (06)
[34] Titin mutation in circulatory tumor DNA is associated with efficacy to immune checkpoint blockade in advanced non-small cell lung cancer
Su, Chunxia
Wang, Xinxin
Zhou, Juan
Zhao, Jing
Zhou, Fei
Zhao, Guodong
Xu, Xiaohong
Zou, Xuan
Zhu, Bo
Jia, Qingzhu
TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (03) : 1256 - +
[35] Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade
Chon, Hong Jae
Lee, Won Suk
Yang, Hannah
Kong, So Jung
Lee, Na Keum
Moon, Eun Sang
Choi, Jiwon
Han, Eun Chun
Kim, Joo Hoon
Ahn, Joong Bae
Kim, Joo Hang
Kim, Chan
CLINICAL CANCER RESEARCH, 2019, 25 (05) : 1612 - 1623
[36] Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non- small cell lung cancer
Herzog, Brett H.
Baer, John M.
Borcherding, Nicholas
Kingston, Natalie L.
Belle, Jad I.
Knolhoff, Brett L.
Hogg, Graham D.
Ahmad, Faiz
Kang, Liang-, I
Petrone, Jessica
Lin, Chieh-Yu
Govindan, Ramaswamy
DeNardo, David G.
SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (699)
[37] Immune Checkpoint Blockade Enhances Immune Activity of Therapeutic Lung Cancer Vaccine
Kadam, Pournima
Singh, Ram P.
Davoodi, Michael
Lee, Jay M.
John, Maie St.
Sharma, Sherven
VACCINES, 2020, 8 (04) : 1 - 9
[38] A High Epigenetic Risk Score Shapes the Non-Inflamed Tumor Microenvironment in Breast Cancer
Zhang, Dong
Wang, Yingnan
Yang, Qifeng
FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
[39] Antibody mediated blockade of phosphatidylserine to enhance immune checkpoint blockade by repolarizing immune suppressive mechanisms of the tumor microenvironment.
Hutchins, Jeff
Gray, Michael J.
Huang, Xianming
Gong, Jian
Hatch, Michaela M. S.
Van Nguyen
Hughes, Christopher C. W.
Brekken, Rolf A.
Freimark, Bruce D.
Gerber, David E.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[40] Modulation of TFH-like cells and anti-tumor activity of immune checkpoint blockade.
Zappasodi, Roberta
Budhu, Sadna
Hellmann, Matthew D.
Postow, Michael A.
Senbabaoglu, Yasin
Manne, Sasikanth
Gasmi, Billel
Liu, Cailian
Zhong, Hong
Li, Yanyun
Huang, Alexander C.
Hirschhorn-Cymerman, Daniel
Panageas, Katherine S.
Wherry, E. John
Merghoub, Taha
Wolchok, Jedd D.
JOURNAL OF IMMUNOLOGY, 2018, 200 (01):

← 1 2 3 4 5 →